封面
市场调查报告书
商品编码
1603302

医用塑胶市场规模、份额、成长分析,按类型、应用、工艺、地区划分 - 产业预测,2024-2031 年

Medical Plastics Market Size, Share, Growth Analysis, By Type(Standard Plastics, Engineering Plastics, High Performance Plastic ), By Application, By Process, By Region - Industry Forecast 2024-2031

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2022年全球医用塑胶市场规模估值为465亿美元,从2023年的501.3亿美元成长到2031年的985.5亿美元,预计在预测期内(2024-2031年)复合年增长率为7.8%。美元。

医用塑胶市场的特点是可以模製成各种形状的聚合物,例如聚碳酸酯、聚丙烯和聚乙烯,由于医疗保健投资的增加和消费者健康意识的提高,预计该市场将显着增长。医用聚合物独特的耐热和耐化学性能使其成为各种医疗设备和仪器(包括手术管)的理想材料。随着可支配收入的增加和消费者生活方式的发展,预计未来几年对医用塑胶的需求将会增强。 2022 年第一季季的医疗设备新增销售量最初因社交距离和封锁而下降,但COVID-19 大流行导致实验室外套、口罩和手套等一次性医疗产品的销售增加,刺激了对医疗器材的需求。个人防护设备(PPE)的一次性使用作为安全通讯协定已经激增,凸显了市场的适应性。儘管疫情带来挑战,但医用塑胶产业正在復苏,预计将稳步恢復势头,反映出该行业在市场动态变化中的韧性。总体而言,全球医用塑胶市场继续在新冠疫情后的格局中前行,同时利用消费者不断变化的健康优先事项,前景仍然乐观。

目录

介绍

  • 研究目的
  • 调查范围
  • 定义

调查方法

  • 资讯采购
  • 二手资料和主要资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 按细分市场的机会分析

市场动态及展望

  • 市场概况
  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 抑制因素和挑战
  • 波特分析及影响
    • 竞争公司之间的敌对关係
    • 替代品的威胁
    • 买方议价能力
    • 新进入者的威胁
    • 供应商的议价能力

主要市场考察

  • 关键成功因素
  • 竞争程度
  • 主要投资机会
  • 市场生态系统
  • 技术进步
  • 监管环境
  • 价值链分析
  • 案例研究分析
  • 客户和购买标准分析
  • PESTEL分析
  • 总体经济指标
  • 市场吸引力指数
  • 原料分析
  • 供应链分析
  • 价格分析

医用塑胶市场规模:按类型和复合年增长率(2024-2031)

  • 标准塑胶
  • 聚氯乙烯(PVC)
  • 聚烯(PE)
  • 聚丙烯(PP)
  • 聚苯乙烯(PS)
  • 聚甲基丙烯酸甲酯 (PMMA)
  • 工程塑料
  • 聚酰胺 (PA)
  • 丙烯腈丁二烯苯乙烯 (ABS)
  • 聚碳酸酯(PC)
  • 聚缩醛
  • 其他的
  • 高性能塑胶(HPP)
  • 聚醚醚酮 (PEEK)
  • 聚四氟乙烯 (PTFE)
  • 聚苯砜 (PPSU)
  • 其他HPPS
  • 硅胶
  • 其他的
  • 热可塑性橡胶(TPE)
  • 热塑性聚氨酯(TPU)
  • 生物分解性聚合物
  • 聚合物共混物和合成橡胶

医用塑胶市场规模:按应用和复合年增长率(2024-2031)

  • 医疗一次性产品
  • 常见的一次性产品
  • 医疗袋
  • 导管
  • 注射器
  • 义肢
  • 义足
  • 植入
  • 医疗设备和工具
  • 手术器械
  • 诊断设备及设备
  • 牙科器械
  • 药物输送
  • 其他的

医用塑胶市场规模:按工艺和复合年增长率(2024-2031)

  • 挤压
  • 射出成型
  • 吹塑成型
  • 其他的

医用塑胶市场规模:按地区和复合年增长率(2024-2031)

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 西班牙
    • 法国
    • 义大利
    • 其他欧洲国家地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东/非洲

竞争资讯

  • 前5名企业对比
  • 主要企业市场定位(2023年)
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市场占有率分析(2023)
  • 主要企业简介
    • 公司简介
    • 产品系列分析
    • 按细分市场分類的份额分析
    • 收益与前一年同期比较(2021-2023)

主要企业简介

  • Rochling SE & Co. KG
  • Nolato AB
  • Saint-Gobain
  • SABIC
  • Eastman Chemical Company
  • Dow, Inc.
  • Solvay SA
  • HMC Polymers Company Limited
  • ARAN BIOMEDICAL TEORANTA
  • Avantor, Inc.
  • Trinseo
  • Evonik Industries AG
  • BASF
  • Covestro
  • Arkema
  • Mitsubishi Chemical Corporation

结论和建议

简介目录
Product Code: SQMIG15E2132

Global Medical Plastics Market size was valued at USD 46.5 billion in 2022 and is poised to grow from USD 50.13 billion in 2023 to USD 98.55 billion by 2031, growing at a CAGR of 7.8% in the forecast period (2024-2031).

The medical plastics market, characterized by polymers such as polycarbonate, polypropylene, and polyethylene that can be molded into diverse shapes, is set for significant growth driven by heightened investments in healthcare and increasing consumer health awareness. The inherent properties of medical-grade polymers, which are resistant to heat and chemicals, position them as ideal materials for a range of medical devices and equipment, including surgical tubing. As disposable incomes rise and consumer lifestyles evolve, demand for medical plastics is expected to intensify in the coming years. Notably, the COVID-19 pandemic spurred demand for disposable medical products, such as test gowns, masks, and gloves, despite an initial dip in new medical device sales during Q1 and Q2 of 2022 attributed to social distancing measures and lockdowns. The preference for single-use personal protective equipment (PPE) surged as a safety protocol, highlighting the adaptability of the market. Although the pandemic presented challenges, the medical plastics sector is rebounding and is expected to steadily regain momentum, reflecting the resilience of the industry amidst changing market dynamics. Overall, the outlook for the global medical plastics market remains positive as it continues to navigate the post-COVID landscape while leveraging evolving consumer health priorities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Medical Plastics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Medical Plastics Market Segmental Analysis

Global Medical Plastics Market is segmented by Type, by Product, by Application, by Process and by Region. Based on Type, the market is segmented into Standard Plastics, Engineering Plastics, High Performance Plastic (HPP), Silicone, and Others. Based on Application, the market is segmented into Medical disposables, Prosthetics, Medical Instruments & Tools, Drug Delivery, and Others. Based on Process, the market is segmented Extrusion, Injection Molding, Blow Molding, Other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Medical Plastics Market

The global Medical Plastics market is being significantly propelled by the increasing demand for recyclable medical plastics, driven largely by the expansion of the medical sector worldwide. The ongoing COVID-19 pandemic has led to a surge in the use of single-use medical plastics and consumables within healthcare facilities, necessitating items such as thermal scanners, ventilators, gloves, respirators, and masks in hospitals, clinics, and diagnostic centers. Additionally, innovations in medical polymers improving biocompatibility are enhancing cost-effectiveness and enabling advancements in targeted drug delivery systems. Furthermore, the rapid development of healthcare infrastructure in emerging markets, coupled with a growing elderly population, is expected to further stimulate market growth.

Restraints in the Global Medical Plastics Market

The Global Medical Plastics market faces significant restraints due to growing concerns about environmental sustainability. The surge in population results in heightened demand for plastic products, which in turn leads to increased plastic production and waste, contributing to environmental pollution. Many medical plastics are non-recyclable and are often discarded individually to manage infection control, complicating waste management efforts. This situation has intensified issues like soil and water degradation. Additionally, the COVID-19 pandemic has escalated plastic use, further straining the environment. Consequently, stringent environmental regulations may adversely impact the demand for medical plastics and stifle industry growth.

Market Trends of the Global Medical Plastics Market

The Global Medical Plastics market is witnessing a notable trend of price volatility driven by fluctuating oil prices, which significantly influences the costs of key polymers such as Polyvinyl Chloride (PVC), Polyethylene (PE), Polypropylene (PP), and Polystyrene (PS). This instability is further compounded by shifts in industry capacity expansions and reductions, particularly in response to demand fluctuations. Additionally, overproduction in the Chinese market is anticipated to exert pressure on raw material prices, creating further uncertainty in the market. Amidst this, companies are adapting strategies to stabilize supply chains, highlighting an ongoing struggle between maintaining market stability and navigating price uncertainties.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Technological Advancement
  • Regulatory Landscape
  • Value Chain Analysis
  • Case Study Analysis
  • Customer & Buying Criteria Analysis
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Market Attractiveness Index
  • Raw Material Analysis
  • Supply Chain Analysis
  • Pricing Analysis

Global Medical Plastics Market Size by Type & CAGR (2024-2031)

  • Standard Plastics
  • Polyvinyl Chloride (PVC)
  • Polyolefin (PE)
  • Polypropylene (PP)
  • Polystyrene (PS)
  • Poly (Methyl Methacrylate) (PMMA)
  • Engineering Plastics
  • Polyamide (PA)
  • Acrylonitrile Butadiene Styrene (ABS)
  • Polycarbonate (PC)
  • Polyacetal
  • Others
  • High Performance Plastic (HPP)
  • Polyetheretherketone (PEEK)
  • Polytetrafluoroethylene (PTFE)
  • Polyphenylsulfone (PPSU)
  • Other HPPS
  • Silicone
  • Others
  • Thermoplastic Elastomer (TPE)
  • Thermoplastic Polyurethane (TPU)
  • Biodegradable Polymers
  • Polymer Blends and Synthetic Rubber

Global Medical Plastics Market Size by Application & CAGR (2024-2031)

  • Medical Disposables
  • General Disposables
  • Medical Bags
  • Catheters
  • Syringes
  • Prosthetics
  • Limb Prosthesis
  • Implants
  • Medical Instruments & Tools
  • Surgical Instruments
  • Diagnostic Instruments & Devices
  • Dental Tools
  • Drug Delivery
  • Others

Global Medical Plastics Market Size by Process & CAGR (2024-2031)

  • Extrusion
  • Injection Molding
  • Blow Molding
  • Other

Global Medical Plastics Market Size by Region & CAGR (2024-2031)

  • North America, (by Type, by Application, by Process)
    • US
    • Canada
  • Europe, (by Type, by Application, by Process)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific, (by Type, by Application, by Process)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America, (by Type, by Application, by Process)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa, (by Type, by Application, by Process)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Rochling SE & Co. KG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nolato AB
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Saint-Gobain
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SABIC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eastman Chemical Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dow, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Solvay S.A.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HMC Polymers Company Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ARAN BIOMEDICAL TEORANTA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Avantor, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Trinseo
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Evonik Industries AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BASF
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Covestro
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Arkema
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mitsubishi Chemical Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation